These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 8452705

  • 21. [Incidence of inflammatory bowel diseases in Bretagne (1994-1995). ABERMAD. Association Bertonne d'Etude et de Recherche des Maladies de l'Appareil Digesif].
    Pagenault M, Tron I, Alexandre JL, Cruchant E, Dabadie A, Chaperon J, Robaszkiewicz M, Bretagne JF.
    Gastroenterol Clin Biol; 1997; 21(6-7):483-90. PubMed ID: 9295976
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M, Zénut M, Aublet-Cuvelier B, Larpent JL, Fabre P, Abergel A, Dapoigny M, Bommelaer G.
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum lysozyme in inflammatory bowel disease.
    Nugent FW, Mallari R, George H, Ridley N.
    Gastroenterology; 1976 Jun; 70(6):1014-6. PubMed ID: 1269861
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z.
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA, De Jesús R, Pérez CM, Iñesta M, Torres D, Morell C, Just E.
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [Abstract] [Full Text] [Related]

  • 29. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC.
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [Abstract] [Full Text] [Related]

  • 30. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Papo M, Quer JC, Pastor RM, García-Pardo G, Olona M, Prats E, Mirapeix E, Rodríguez R, Richart C.
    Med Clin (Barc); 1998 Jan 17; 110(1):11-5. PubMed ID: 9527980
    [Abstract] [Full Text] [Related]

  • 31. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P, Argüello L, Hoyos M, Ramírez JJ, Hinojosa J, Molés JR, García A, Berenguer M, Berenguer J.
    Rev Esp Enferm Dig; 1996 Jul 17; 88(7):470-4. PubMed ID: 8924324
    [Abstract] [Full Text] [Related]

  • 32. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease.
    Cakal B, Gokmen A, Yalinkilic M, Cakal E, Ayaz S, Nadir I, Ozin Y, Dagli U, Ulker A.
    Blood Coagul Fibrinolysis; 2010 Mar 17; 21(2):118-21. PubMed ID: 20040858
    [Abstract] [Full Text] [Related]

  • 33. Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity?
    Gouni-Berthold I, Baumeister B, Wegel E, Berthold HK, Vetter H, Schmidt C.
    Hepatogastroenterology; 1999 Mar 17; 46(28):2315-20. PubMed ID: 10521989
    [Abstract] [Full Text] [Related]

  • 34. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M, Papa A, Nista EC, Danese S, Armuzzi A, Bartolozzi F, Tondi P, Ojetti V, Gasbarrini G, Gasbarrini A.
    Hepatogastroenterology; 2003 Mar 17; 50(51):718-20. PubMed ID: 12828069
    [Abstract] [Full Text] [Related]

  • 35. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
    Masoodi I, Kochhar R, Dutta U, Vaishnavi C, Prasad KK, Vaiphei K, Kaur S, Singh K.
    J Gastroenterol Hepatol; 2009 Nov 17; 24(11):1768-74. PubMed ID: 20136960
    [Abstract] [Full Text] [Related]

  • 36. Determining disease activity in inflammatory bowel disease.
    Cooke WT, Prior P.
    J Clin Gastroenterol; 1984 Feb 17; 6(1):17-25. PubMed ID: 6699391
    [Abstract] [Full Text] [Related]

  • 37. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ.
    Clin Gastroenterol Hepatol; 2008 Nov 17; 6(11):1218-24. PubMed ID: 18799360
    [Abstract] [Full Text] [Related]

  • 38. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C, Descos L, André F, Vignal J, Druguet M.
    Gastroenterol Clin Biol; 1979 Nov 17; 3(11):789-94. PubMed ID: 527789
    [No Abstract] [Full Text] [Related]

  • 39. Inflammatory bowel disease in Kuwait.
    Al-Nakib B, Radhakrishnan S, Jacob GS, Al-Liddawi H, Al-Ruwaih A.
    Am J Gastroenterol; 1984 Mar 17; 79(3):191-4. PubMed ID: 6702804
    [Abstract] [Full Text] [Related]

  • 40. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).
    Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R, Tatarella M.
    Eur J Gastroenterol Hepatol; 1999 Aug 17; 11(8):909-13. PubMed ID: 10514127
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.